Literature DB >> 14698486

Hemorrhagic sympathoinhibition mediated through the periaqueductal gray in the rat.

Caron Dean1.   

Abstract

In response to hemorrhage in the anesthetized rat, an initial renal sympathoexcitation is followed by profound sympathoinhibition and hypotension with increasing blood loss. Microinjection of the gamma-aminobutyric acid(A) agonist muscimol to block neurotransmission through the sympathoinhibitory region of the ventrolateral periaqueductal gray matter (vlPAG) did not alter resting sympathetic nerve activity or blood pressure. However, the response to hemorrhage was converted to a maintained renal sympathoexcitation with a delayed and attenuated accompanying hypotension. These data indicate that neurons in the vlPAG mediate the sympathetic and cardiovascular responses to severe hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14698486     DOI: 10.1016/j.neulet.2003.09.054

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Daily voluntary exercise alters the cardiovascular response to hemorrhage in conscious male rats.

Authors:  Joslyn K Ahlgren; Linda F Hayward
Journal:  Auton Neurosci       Date:  2011-01-06       Impact factor: 3.145

2.  Modulation of heart rate variability during severe hemorrhage at different rates in conscious rats.

Authors:  Karen Porter; Joslyn Ahlgren; Jessie Stanley; Linda F Hayward
Journal:  Auton Neurosci       Date:  2009-05-23       Impact factor: 3.145

3.  Behavioral consequences of delta-opioid receptor activation in the periaqueductal gray of morphine tolerant rats.

Authors:  Michael M Morgan; Michelle D Ashley; Susan L Ingram; MacDonald J Christie
Journal:  Neural Plast       Date:  2009-02-25       Impact factor: 3.599

4.  Role of the glutamatergic system of ventrolateral periaqueductal gray (vlPAG) in the cardiovascular responses in normal and hemorrhagic conditions in rats.

Authors:  Vida Alikhani; Reza Mohebbati; Mahmoud Hosseini; Abolfazl Khajavirad; Mohammad Naser Shafei
Journal:  Iran J Basic Med Sci       Date:  2021-05       Impact factor: 2.699

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.